Forat Lutfi

7PUBLICATIONS
45CO-AUTHORS
Liquid biopsiesGene and molecular therapyCardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 18, 2026
TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers.

|Jun 25, 2026
Evaluation of Real-World Studies on Management of Relapsed Multiple Myeloma After BCMA-Directed Therapy Failure from U.S. Academic Centers and USMIRC.

|May 26, 2026
High-Risk Cytogenetic Multiple Myeloma Remains a Therapeutic Challenge: A 15-Year Real-World Analysis.

|May 12, 2026
Real-World Experience With a ZUMA-1 Cohort 4 Adopted Approach to CRS and ICANS in CAR-T Recipients.

|Mar 27, 2026
Maintenance Strategies in High-Risk Myeloma: A Multicenter Comparison of Bortezomib-Lenalidomide Versus Lenalidomide Alone: A USMIRC Multicenter Analysis.

Sruthi P Ramanan, Oyepeju F Abioye, Shebli Atrash

|Sep 09, 2021
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma.

Forat Lutfi, Noa G Holtzman, Ankit J Kansagra

Pageof 2

Frequent Collaborators

3 joint publications

Ali Bukhari

3 joint publications

Shebli Atrash

3 joint publications

Prerna Mewawalla

3 joint publications

Anita Mazloom